SALT
LAKE CITY, Sept. 14, 2022 /PRNewswire/ --
Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or
"Co-Dx"), a molecular diagnostics company with a unique, patented
platform for the development of molecular diagnostic tests,
announced today that the Company will be sponsoring, presenting and
hosting a booth at the Caribbean Public Health Agency (CARPHA)
66th Annual Health Research Conference, being held
virtually and in-person on September
15-17 in Jamaica.
This year's theme for the conference is "COVID-19 and Digital
Health: Transforming, Connecting, Informing Public Health." Co-Dx
has been attending the CARPHA conference since 2016, and the
Company's booth and presentation will showcase Co-Diagnostics'
infectious disease and vector control products to conference
attendees, along with its upcoming Co-Dx PCR Home testing
platform.
The Company's presentation will take place on Friday, September 16 at 10:15 am local time. Additional details,
including registration information, can be found on the conference
website.
About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a
Utah corporation, is a molecular
diagnostics company that develops, manufactures and markets
state-of-the-art diagnostics technology. The Company's technology
is utilized for tests that are designed using the detection and/or
analysis of nucleic acid molecules (DNA or RNA). The Company also
uses its proprietary technology to design specific tests to locate
genetic markers for use in industries other than infectious disease
and license the use of those tests to specific customers.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-sponsor-present-and-host-booth-at-66th-annual-carpha-conference-on-sept-15-17-in-jamaica-301624284.html
SOURCE Co-Diagnostics